Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The effect of increasing doses of pegfilgrastim (Peg) on thrombocytopenia (T) in breast cancer (BC) patients (pts) receiving taxotere (Doc), doxorubicin, cyclophosphamide (TAC) and plinabulin (Plin) Blayney, D. W., Bondarenko, I., Shi, Y., Ogenstad, S., Du, L., Huang, L., Mohanlal, R. OXFORD UNIV PRESS. 2019: 737
View details for Web of Science ID 000491295505082